Related Experiment Video
Updated: Jan 21, 2026

Enema of Traditional Chinese Medicine for Patients with Severe Acute Pancreatitis
Published on: January 27, 2023
ABCB1 Gene Is Associated With Clinical Response to SNRIs in a Local Chinese Han Population
Xiao-Xiao Shan1,2, Yan Qiu1,2, Wei-Wei Xie3
1Department of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, China.
Insights
The ATP-binding cassette subfamily B member 1 (ABCB1) gene showed no association with selective serotonin reuptake inhibitor (SSRI) treatment response in major depressive disorder (MDD) patients. However, the ABCB1 rs2032583 polymorphism may predict improved response to serotonin-norepinephrine reuptake inhibitors (SNRIs).
Area of Science:
- Pharmacogenetics
- Neuroscience
- Genetics
Background:
- The ATP-binding cassette subfamily B member 1 (ABCB1) gene has been implicated in major depressive disorder (MDD).
- Previous studies in Chinese Han populations suggest associations between specific ABCB1 single-nucleotide polymorphisms (SNPs) and MDD, though findings vary.
- Understanding the role of ABCB1 in treatment response is crucial for personalized medicine in MDD.
Purpose of the Study:
- To investigate the association between ABCB1 gene polymorphisms and therapeutic responses to selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).
- To explore the predictive value of ABCB1 SNPs for treatment outcomes in a Chinese Han population with MDD.
Main Methods:
- A cohort of 292 MDD patients was recruited from a local Chinese Han population.
- Patients were treated with either SSRIs or SNRIs and assessed weekly for six weeks using the 17-item Hamilton Rating Scale for Depression (HAM-D17).
- Genotyping of six ABCB1 SNPs was performed, and their distribution was compared between treatment responders and non-responders.
Main Results:
- No significant differences in genotype or allele distribution of the six studied ABCB1 SNPs were found between responders and non-responders in the SSRI therapy group.
- In the SNRI therapy group, the ABCB1 rs2032583 polymorphism was significantly associated with therapeutic response.
- Logistic regression analysis indicated that the C allele of ABCB1 rs2032583 was negatively correlated with treatment response to SNRIs, suggesting the TT genotype may predict better outcomes.
Conclusions:
- ABCB1 gene polymorphisms do not appear to be associated with therapeutic responses to SSRIs in this MDD cohort.
- The rs2032583 polymorphism in the ABCB1 gene may serve as a predictive factor for improved treatment response to SNRIs among Chinese patients with MDD.
- Further validation in larger, diverse patient cohorts is recommended to confirm these findings.
Abstract:
Background: The relation between the ATP-binding cassette subfamily B member 1 (ABCB1) gene and major depressive disorder (MDD) has been studied in a local Chinese Han population. MDD is associated with the rs2032582 (G2677T) and rs1128503 (C1236T) single-nucleotide polymorphisms (SNPs) of ABCB1 but not with rs1045642, rs2032583, rs2235040, and rs2235015. This study aims to explore the potential correlations of therapeutic responses with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) in a local Chinese Han population. Methods: The study population included 292 patients with MDD. All patients were assessed at baseline and at first, second, fourth, and sixth weeks according to the 17-item Hamilton Rating Scale for Depression (HAM-D17) to determine their therapeutic responses to SSRIs and SNRIs. Results: In the SSRI therapy group, the genotype or allele distribution of six SNPs was not significantly different between responders and nonresponders. In the SNRI therapy group, only rs2032583 was associated with a therapeutic response to SNRIs. The C allele of the ABCB1 rs2032583 polymorphism was negatively correlated with therapeutic responses according to logistic regression analysis. Conclusion: The ABCB1 gene polymorphisms may not be associated with therapeutic responses to SSRIs but not with SNRIs. The TT genotype of rs2032583 could be a predictive factor of improved treatment responses to SNRIs in the Chinese population. These findings should be replicated in future studies with larger patient groups.
Related Concept Videos
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
What is Population Genetics?
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Conservation of Small Populations

